Glutamate dehydrogenase mutant and application thereof

US11339380B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11339380-B2
Application numberUS-201916684509-A
CountryUS
Kind codeB2
Filing dateNov 14, 2019
Priority dateMay 15, 2019
Publication dateMay 24, 2022
Grant dateMay 24, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention discloses a glutamate dehydrogenase mutant and an application thereof. The mutant is one of the following: a mutant of the amino acid sequence of SEQ ID NO. 1 which has a mutation at lysine at position 402 to phenylalanine or aspartic acid; a mutant which has a mutation at isoleucine at position 406 to phenylalanine or threonine; a mutant which has a mutation at threonine at position 121 and leucine at position 123; a mutant which has a mutation at alanine at position 379 and leucine at position 383. In the invention, the catalytic activity of glutamate dehydrogenase derived from Pseudomonas putida to 2-carbonyl-4-(hydroxymethylphosphonoyl)butanoic acid (PPO) is significantly improved by a molecular transformation method combining directed evolution and a semi-rational design; and the issue of low glutamate dehydrogenase activity in the process of preparing L-glufosinate by reductive amination is solved.

First claim

Opening claim text (preview).

What is claimed is: 1. A method for preparing L-glufosinate by catalyzing 2-carbonyl-4-(hydroxymethylphosphonoyl)butanoic acid or a salt thereof, comprising: (1) preparing a genetically-engineered bacteria expressing a glutamate dehydrogenase mutant, wherein the genetically-engineered bacteria is E. coli; (2) culturing the genetically-engineered bacteria to prepare an enzyme solution; (3) adding the enzyme solution to a system containing a substrate 2-carbonyl-4-(hydroxymethylphosphonoyl)butanoic acid, an amino donor, and a reduced coenzyme and performing a reductive amination reaction to obtain L-glufosinate, wherein the glutamate dehydrogenase mutant is one of the following: (a) the amino acid sequence of SEQ ID NO. 1 except for having a mutation of lysine at position 402 to phenylalanine or aspartic acid; (b) the amino acid sequence of SEQ ID NO. 1 except for having a mutation of threonine at position 121 and leucine at position 123 respectively to serine and histidine, or asparagine and tyrosine, or valine and tyrosine, or serine and serine, or asparagine and phenylalanine, or valine and phenylalanine, or isoleucine and tyrosine; (c) the amino acid sequence of SEQ ID NO. 1 except for having a mutation of alanine at position 379 and leucine at position 383 respectively to isoleucine and tyrosine, or isoleucine and cysteine, or serine and tyrosine, or valine and serine, or phenylalanine and cysteine, or tyrosine and cysteine, or cysteine and cysteine. 2. The method for preparing L-glufosinate by catalyzing 2-carbonyl-4-(hydroxymethylphosphonoyl)butanoic acid or a salt thereof of claim 1 , wherein in step (3), a temperature of the reductive amination reaction is 15° C. to 50° C., and a pH of the reaction solution is 6 to 10. 3. The method for preparing L-glufosinate by catalyzing 2-carbonyl-4-(hydroxymethylphosphonoyl)butanoic acid or a salt thereof of claim 1 , wherein in step (3), the reduced coenzyme is NADPH. 4. The method for preparing L-glufosinate by catalyzing 2-carbonyl-4-(hydroxymethylphosphonoyl)butanoic acid or a salt thereof of claim 1 , wherein the reaction system of step (3) further comprises a coenzyme regeneration system; and the coenzyme regeneration system is a coenzyme regeneration system that uses glucose dehydrogenase as a coenzyme regenerating enzyme and glucose as a coenzyme regeneration substrate. 5. The method for preparing L-glufosinate by catalyzing 2-carbonyl-4-(hydroxymethylphosphonoyl)butanoic acid or a salt thereof of claim 4 , wherein the amino acid sequence of the glucose dehydrogenase is SEQ ID NO. 2. 6. The method for preparing L-glufosinate by catalyzing 2-carbonyl-4-(hydroxymethylphosphonoyl)butanoic acid or a salt thereof of claim 1 , wherein in step (3), the amino donor is ammonium sulfate.

Assignees

Inventors

Classifications

  • Glutamate dehydrogenase (NADP+) (1.4.1.4) · CPC title

  • Amines; Imines · CPC title

  • Alpha- or beta- amino acids {(other amino acids C12P13/005)} · CPC title

  • Glutamate dehydrogenase (1.4.1.2) · CPC title

  • Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11339380B2 cover?
The invention discloses a glutamate dehydrogenase mutant and an application thereof. The mutant is one of the following: a mutant of the amino acid sequence of SEQ ID NO. 1 which has a mutation at lysine at position 402 to phenylalanine or aspartic acid; a mutant which has a mutation at isoleucine at position 406 to phenylalanine or threonine; a mutant which has a mutation at threonine at posit…
Who is the assignee on this patent?
Univ Zhejiang
What technology area does this patent fall under?
Primary CPC classification C12N9/0016. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue May 24 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).